Fibroblast Growth Factor 23 in Patients Undergoing Peritoneal Dialysis
[摘要] Background and objectives Fibroblast growth factor 23 (FGF23) is an independent risk factor for mortality in patients with ESRD. Before FGF23 testing can be integrated into clinical practice of ESRD, further understanding of its determinants is needed.
[发布日期] [发布机构]
[效力级别] [学科分类] 泌尿医学
[关键词] Bone marrow necrosis;Sickle cell disease;Hyperhemolysis syndrome [时效性]